Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection
Author:
Funder
Università degli Studi di Napoli Federico II
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s40261-022-01163-5.pdf
Reference47 articles.
1. Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80:1029–72. https://doi.org/10.1016/j.jaad.2018.11.057.
2. Nast A, Altenburg A, Augustin M, Boehncke WH, Härle P, Klaus J, et al. German S3 guideline on the treatment of psoriasis vulgaris, adapted from EuroGuiDerm. Part 1: treatment goals and treatment recommendations. J Dtsch Dermatol Ges. 2021;19:934–150. https://doi.org/10.1111/ddg.14508.
3. Gisondi P, Altomare G, Ayala F, Bardazzi F, Bianchi L, Chiricozzi A, et al. Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis. J Eur Acad Dermatol Venereol. 2017;31:774–90. https://doi.org/10.1111/jdv.14114.
4. Gisondi P, Talamonti M, Chiricozzi A, Piaserico S, Amerio P, Balato A, et al. Treat-to-target approach for the management of patients with moderate-to-severe plaque psoriasis: consensus recommendations. Dermatol Ther. 2021;11:235–52. https://doi.org/10.1007/s13555-020-00475-8.
5. Megna M, Balato A, Napolitano M, Gallo L, Caso F, Costa L, et al. Psoriatic disease treatment nowadays: unmet needs among the “jungle of biologic drugs and small molecules.” Clin Rheumatol. 2018;37:1739–41. https://doi.org/10.1007/s10067-018-4090-6.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The use of secukinumab in patients with chronic infections;JEADV Clinical Practice;2024-01-20
2. Infectious Disease Screening prior to Systemic Immunomodulatory Therapy in Hidradenitis Suppurativa: Consensus Guidelines from the Asia-Pacific Hidradenitis Suppurativa Foundation;Dermatology;2023-11-14
3. Safety of secukinumab in the treatment of patients with axial spondyloarthritis and concurrent hepatitis B virus infection or latent tuberculosis infection;Clinical Rheumatology;2023-05-23
4. Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy;Journal of Dermatological Treatment;2023-05-16
5. Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection;Clinical, Cosmetic and Investigational Dermatology;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3